Paul Allen’s Big Bet to ‘Uncover the Essence of What Makes Us Human’
Following his second brush with cancer a couple of years ago, billionaire Paul Allen had some time to think about the legacy he’ll leave, beyond being the co-founder of Microsoft. Yesterday, he made clear that he wants to be the guy who helped spark new understanding of the human brain.
“I’ve always been fascinated by the workings of the human brain, and awed by its enormous complexity,” Allen said at a press conference announcing his new $300 million commitment to brain science. “Our brains are many magnitudes more advanced, in the way they work, than any computer software.” He added: “Our dream is to uncover the essence of what makes us human.”
There was a lot more ambitious rhetoric going around yesterday at this press conference, in which Allen announced his plan to supercharge the efforts of the Seattle-based nonprofit Allen Institute for Brain Science. The four-year, $300 million commitment from Allen brings his total support for the nonprofit center to more than $500 million since its founding in 2003. This massive new push for brain science drew press attention from the big guns at the Wall Street Journal, New York Times, Forbes, Bloomberg News, and Time, as well as a litany of local biotech power brokers. Lee Hood of the Institute for Systems Biology, Larry Corey of the Fred Hutchinson Cancer Research Center, Ken Stuart of Seattle Biomedical Research Institute, and Chris Rivera of the WBBA were among those who turned out, and generally beamed about Allen’s big new contribution.
“It’s enormously valuable, exactly the right thing to do,” Hood said afterward, noting that the Allen Institute has adopted the Institute for Systems Biology’s multi-disciplinary “big science” approach. Corey, who personally buttonholed Allen after the press conference, said “It’s wonderful for Seattle.”
For those who missed the story yesterday, here’s the gist. The Allen Institute will roughly double in size, from 185 people today to 350 over the next four years, to carry out a new mission that charges way beyond what it has done in its first nine years. So far, the institute has created unique, functional gene expression maps of the mouse brain, the human brain, and spinal cords. All of this is put out in the public domain, and is freely accessible to researchers at universities, biotech companies, and pharmaceutical companies. CEO Allan Jones said the institute hopes to complete its sixth human brain map by the end of this year.
The three new initiatives are hugely complex, and to my ear, sounded breathtaking in their scope and ambition. “The job gets a lot tougher now. We’re going to tackle some of the biggest challenges in science today,” Allen said. “My commitment doesn’t just continue the work of the institute—it greatly expands scope of institute. We hope to fuel more discoveries in neuroscience.”
So what does the institute plan to do with that money? Here’s a basic rundown of what the institute’s three new initiatives are about, based on the very speedy descriptions of chief scientist Christof Koch (thank goodness for digital recorders, otherwise I would never have been able to get everything he said.)
—First, the institute will seek to better understand how the brain stores, encodes, and processes information in networks. The institute plans to build what it calls “brain observatories” of the cerebral cortex in mammals. These observatories will be made up of a range of sophisticated instruments and computers to “exhaustively identify, catalog, record, intervene in the cognitive networks underlying visual perception, visual behavior, and visual consciousness in the mouse,” Koch said.
—Second, the institute will seek to create a comprehensive catalog of the types of neurons in the human and mouse cerebral cortex. “We want to create an exhaustive and comprehensive taxonomy,” Koch said. “Expanding on our past Atlas work, we will use the brain observatories to ascertain the behavior, shape, form, the connections and biochemistry of these cells.” When complete, it will be the first full picture of the brain’s cellular building blocks. “We’ll count and classify every neuron in the mouse visual system, and visualize their activity throughout the brain, from eyes to muscles in mice,” Koch said. Unlike functional MRI imaging tests of today, which look at regions of the brain that get activated during certain activities, the Allen Institute looks to drill much deeper. “Our brain observatories will be able to listen to individual neurons,” Koch said. “That’s critical because it’s the neurons that are the atoms of perception, of thought, of memory, of consciousness.”
With the emerging technology of what he called “optogenetics”—sort of like “deep-brain stimulation on steroids”—Koch said “we’ll be able to turn groups of specified neurons on or off at will, and to observe the effect of this manipulation on the behavior of the animal.” Computer models will then be used to help explain and predict what is going on in the brain, he said.
—Third, the institute will look deeper than the cellular level, down to the molecular level of the brain. This will be based on using high-speed/low-cost gene sequencing machines to spot DNA mutations that affect brain development and can lead to disease. The other key technology in this initiative will be the use of what scientists call “induced pluripotent stem cells” in which adult skin or blood cells are essentially re-programmed into a stem-cell like state so that they can become any type of cell in the body—including many types of neurons. By looking at DNA mutations, and then seeing how that DNA manifests itself in actual neurons from people, the scientists hope to be able to predict how brains will function. “Our ultimate goal is to generate a set of molecular tools that will empower the scientific community” to develop better understanding of how aberrant genes affect behavior and various diseases, Koch said.
There will obviously be big challenges in pulling off this kind of work, aside from the sheer technical difficulty. Jones, the institute’s CEO, said his 185 employees are spread among three buildings in Fremont, and it would be better for collaboration to be clustered under one roof (he hinted that he’s working on that one). For Koch, there’s a sociological challenge in recruiting bright scientific minds. Since top scientists tend to be independent sorts who work in narrow disciplines, and tend to follow their own latest ideas. The culture is about keeping ideas and data secret until blockbuster results get published in a peer-reviewed journal. That’s the opposite of an open-source effort, in which each individual can’t just follow whatever idea strikes them, and keep all the data and glory for themselves. “This is a team effort,” Koch says. “We have to attract the world’s best talent, and then instill in them a team spirit that we all have to work together, for common goals, common methods.”
More than once, Allen talked about the complexity involved in the work, and how daunting it is. When Koch tried to sum up what this effort is about, it’s not the kind of thing you can very easily put in a single sentence.
“We have a unique opportunity to truly push the field forward,” Koch said. “This is a large-scale, industrial-size effort to synthesize all of our genomic, anatomical, physiological, computational, and theoretical knowledge into a comprehensive picture of how the most complex piece of organized matter, the brain, develops and functions to produce perception, memory, and consciousness.”
If you’re like me, you probably had to read that sentence more than once. It’s a big undertaking, and all the answers neuroscientists want won’t magically appear at the end of four years. Koch acknowledged that it’s likely to turn out like cosmology—once scientists learn a bit more about the universe, they realize there’s a lot more there to explore than previously thought.
But for Allen, a guy who grew up on science fiction, this is partly about exploration of new frontiers, and partly about a desire to make an impact on humanity and health.
“I’ve always been fascinated by the brain,” Allen said. “I started out as a programmer in high school, and the brain works in a completely different and unknown fashion than the way computers do. There is no greater challenge, with potentially huge impact, than understanding how brains work. For me, it’s fascinating. And as someone who’s been touched by neurodegenerative diseases—my mother has Alzheimer’s, for example—I want to see cures brought forward.”
Trending on Xconomy
By posting a comment, you agree to our terms and conditions.